| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/16/1996 | US5484795 Naphthyl compounds, intermediates, processes, compositions, and method of inhibiting restenosis |
| 01/16/1996 | US5484793 Nervous system disorders; cognition activators; alzheimer*s disease |
| 01/16/1996 | US5484792 Drugs for treatment of urinary incontinence |
| 01/16/1996 | US5484791 Carbamates of rapamycin |
| 01/16/1996 | US5484790 Carbamates of rapamycin |
| 01/16/1996 | US5484789 Calcium channel blockers to improve preservation of organs stored for transplantation |
| 01/16/1996 | US5484788 Buspirone as a systemic immunosuppressant |
| 01/16/1996 | US5484785 Salts of a quinolone-carboxylic acid |
| 01/16/1996 | US5484783 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives |
| 01/16/1996 | US5484782 (E)-20(22)-dehydrovitamin D compounds |
| 01/16/1996 | US5484781 (E)-20(22)-dehydrovitamin D compounds |
| 01/16/1996 | US5484780 Angiotensin II antagonists |
| 01/16/1996 | US5484778 Anticarcinogenic agents or antitumor agents |
| 01/16/1996 | US5484776 Process for the production of stable liquid form of beta-blocker-containing medicaments with controlled release of the active constituent for oral administration |
| 01/16/1996 | US5484775 Semisynthetic ganglioside analogues |
| 01/16/1996 | US5484774 2, N6 -disubstituted adenosines, tri-O-ester derivatives and their pharmaceutical compositions to treat ischemias |
| 01/16/1996 | US5484715 Method for preparing an antitumor dextran using a dextran synthetase from Lactobacillus confusus |
| 01/16/1996 | US5484712 Method for producing aclacinomycins A, B, Y using Strepomyces lavendofoliae DKRS |
| 01/16/1996 | US5484612 Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin |
| 01/16/1996 | US5484608 Sustained-release drug delivery system |
| 01/16/1996 | US5484607 Extended release clonidine formulation |
| 01/16/1996 | US5484605 Agent for treating chronically inflammatory intestinal diseases |
| 01/16/1996 | US5484603 Percutaneous anaesthesia |
| 01/16/1996 | US5484602 Drug contained in lollipop |
| 01/16/1996 | US5484595 Process for preparation of dibenzocyclooctadiene type lignan |
| 01/16/1996 | US5484584 Therapeutic and diagnostic use of modified polymeric microcapsules |
| 01/16/1996 | CA1337937C Tricyclic 3-oxo-propanenitrile derivatives and process for their preparation |
| 01/16/1996 | CA1337931C Treatment of periodontoclasia with retinoic acid |
| 01/16/1996 | CA1337930C Method of treating skin injuries using thromboxane a__ receptor antagonists |
| 01/16/1996 | CA1337928C Topically applied gold organic complex |
| 01/16/1996 | CA1337927C Suppression of eczematous dermatitis by calcium transport inhibition |
| 01/14/1996 | CA2153726A1 .alpha.-(4-chlorophenyl)-4-[(4-fluorophenyl)-methyl]piperidine-1- ethanol esters, their preparation and their therapeutic application |
| 01/13/1996 | CA2153605A1 Treatment of hyperkinetic disorders |
| 01/11/1996 | WO1996000797A1 Methods of screening for nucleoside analogs that are incorporated by hiv reverse transcriptase and cause incorrect base pairing |
| 01/11/1996 | WO1996000790A1 Adenovirus including a gene coding for a superoxide dismutase |
| 01/11/1996 | WO1996000738A1 Endothelin antagonists ii |
| 01/11/1996 | WO1996000736A1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
| 01/11/1996 | WO1996000732A1 Phosphinic acid derivatives |
| 01/11/1996 | WO1996000730A1 Vitronectin receptor antagonists |
| 01/11/1996 | WO1996000726A2 New brefeldin a derivatives and their utility in the treatment of cancer |
| 01/11/1996 | WO1996000725A1 (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants |
| 01/11/1996 | WO1996000724A1 7-ether-taxol analogs, antineoplastic use and pharmaceutical compositions containing them |
| 01/11/1996 | WO1996000720A1 Aryl and heteroaryl alkoxynaphthalene derivatives |
| 01/11/1996 | WO1996000716A1 New salts of 2-[(2,6-dichlorophenyl)amine]phenylacetoxyacetic acid with organic basic cations |
| 01/11/1996 | WO1996000588A1 Low viscosity chelating polymers |
| 01/11/1996 | WO1996000584A1 Anti-inflammatory wound healing compositions and methods for preparing and using same |
| 01/11/1996 | WO1996000574A1 Vitronectin receptor antagonists |
| 01/11/1996 | WO1996000572A1 Antikeratolytic-wound healing compositions and methods for preparing and using same |
| 01/11/1996 | WO1996000571A1 Antibacterial agent |
| 01/11/1996 | WO1996000570A1 Antibacterial agent |
| 01/11/1996 | WO1996000569A1 Pharmaceutical compositions containing triclosan or derivatives thereof and edta or egta |
| 01/11/1996 | WO1996000568A1 Anti-metastatic agent |
| 01/11/1996 | WO1996000567A1 Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanocrystal formulation |
| 01/11/1996 | WO1996000537A1 Microcapsules for administration of neuroactive agents |
| 01/11/1996 | WO1996000503A1 Novel peptides |
| 01/11/1996 | DE4425857A1 Kaskaden-Polymer-Komplexe, Verfahren zur ihrer Herstellung und diese enthaltende pharmazeutische Mittel Cascade polymer complexes, process for their preparation and pharmaceutical compositions containing them |
| 01/11/1996 | DE4423915A1 New tocopheryl esters of sulphasalazine or 5-amino-salicyclic acid |
| 01/11/1996 | DE4423850A1 Transdermal delivery device for naloxone hydrochloride |
| 01/11/1996 | DE4423416A1 Oral compsn. contg. opioid analgesic and papaverine |
| 01/11/1996 | DE4422259A1 Anti-Sinn-Oligonukleotide zur Aromatase-Inhibierung Antisense oligonucleotides for aromatase inhibition |
| 01/11/1996 | DE4418690A1 Nucleoside 5'-mono-phosphate ester(s) of glyceryl di:ether derivs. |
| 01/11/1996 | CA2193966A1 Vitronectin receptor antagonists |
| 01/11/1996 | CA2193865A1 Antibacterial agent |
| 01/11/1996 | CA2193704A1 New brefeldin a derivatives and their utility in the treatment of cancer |
| 01/11/1996 | CA2193367A1 (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants |
| 01/11/1996 | CA2193104A1 Pharmaceutical compositions containing triclosan or derivatives thereof and edta or egta |
| 01/11/1996 | CA2192957A1 Semenogelin-derived oligopeptides cleavable by prostate specific antigen |
| 01/11/1996 | CA2192682A1 New salts of 2-¬(2,6-dichlorophenyl)amine|phenylacetoxyacetic acid with organic basic cations |
| 01/11/1996 | CA2191878A1 Low viscosity chelating polymers |
| 01/11/1996 | CA2191605A1 Antikeratolytic-wound healing compositions and methods for preparing and using same |
| 01/11/1996 | CA2191604A1 Anti-inflammatory wound healing compositions and methods for preparing and using same |
| 01/11/1996 | CA2191224A1 7-ether-taxol analogs, antineoplastic use and pharmaceutical compositions containing them |
| 01/11/1996 | CA2190977A1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
| 01/11/1996 | CA2190883A1 Adenovirus including a gene coding for a superoxide dismutase |
| 01/11/1996 | CA2190756A1 Endothelin antagonists ii |
| 01/10/1996 | EP0691407A1 Non-reducing saccharide and its production and use |
| 01/10/1996 | EP0691345A2 HIV protease inhibitor combinations |
| 01/10/1996 | EP0691344A1 Purification of trehalose |
| 01/10/1996 | EP0691342A1 Benzopyrane derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/10/1996 | EP0691341A1 Benzopyrancarboxamide derivatives, salt thereof, process for the preparation of same and use thereof |
| 01/10/1996 | EP0691340A1 1-Azabicyclo 3.3.0 octan derivative, salt thereof, process for the preparation of same and use thereof |
| 01/10/1996 | EP0691339A1 Amine derivatives of 1,3-dihydro-2H-pyrrolo(2,3-b)pyridin-2-ones and oxazolo(4,5-b)pyridin-2(3H)-ones, their process of preparation and pharmaceutical compositions containing them |
| 01/10/1996 | EP0691333A2 Pyrimidine derivatives, process for their preparation and their use as precursors |
| 01/10/1996 | EP0691327A1 Amine derivative and dermatologic preparation containing the same |
| 01/10/1996 | EP0691130A1 Use of rapamycin in the manufacture of a medicament for preventing and heating hyperproliferactive vascular diseases, eventually in combination with mycophenolic acid |
| 01/10/1996 | EP0691129A2 Thiazolidone and pyrrolidinone compounds for inhibiting bone loss |
| 01/10/1996 | EP0691128A1 Methods of administering CRF antagonists |
| 01/10/1996 | EP0691126A1 Cosmetic or dermatological compositions containing alpha hydroxy carboxylic acids and/or keto carboxylic acids and inorganic pigments |
| 01/10/1996 | EP0691079A2 Enteral composition for diabetic patients |
| 01/10/1996 | EP0690915A1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 01/10/1996 | EP0690904A1 Unsaponifiable materials of vegetable origin and cosmetic compositions containing same |
| 01/10/1996 | EP0690871A1 Growth differentiation factor-5 |
| 01/10/1996 | EP0690867A1 Taxanes having furyl or thienyl substituted side-chain |
| 01/10/1996 | EP0690865A1 Crystalline benzathine salt of cefonicid and its preparation |
| 01/10/1996 | EP0690864A1 Crystalline ceftiofur free acid |
| 01/10/1996 | EP0690863A1 Tetracyclic compounds as dopamine agonists |
| 01/10/1996 | EP0690862A1 Novel quinolone derivatives and processes for preparing the same |
| 01/10/1996 | EP0690859A1 Benzylimidazopyridine derivatives as angiotensin ii receptor antagonists |
| 01/10/1996 | EP0690856A1 Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment |
| 01/10/1996 | EP0690854A1 1-phenyl-imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders |